Zobrazeno 1 - 10
of 14
pro vyhledávání: '"D S Siegel"'
Autor:
B. Paul, M. Liedtke, D. S. Siegel, J. Khouri, J. Hillenglass, R. Rifkin, M. D. Gandhi, A. Kin, M. Y. Levy, A. Mohrbacher, W. Schmidt, R. Silbermann, F. Cottini, D. W. Sborov, R. Walker, M. Murphy, L. Gu, A. Chen, N. Rajakumaraswamy, S. Z. Usmani
Publikováno v:
HemaSphere, Vol 6, Pp 1883-1884 (2022)
Externí odkaz:
https://doaj.org/article/8648f65b79f1423b8a002f37e0a46fcf
Autor:
P. G. Richardson, C. C. Hofmeister, N. S. Raje, D. S. Siegel, S. Lonial, J. Laubach, Y. A. Efebera, D. H. Vesole, A. K. Nooka, J. Rosenblatt, D. Doss, M. H. Zaki, A. Bensmaine, J. Herring, Y. Li, L. Watkins, M. S. Chen, K. C. Anderson
Publikováno v:
Leukemia
This phase 1 dose-escalation study evaluated pomalidomide, bortezomib (subcutaneous (SC) or intravenous (IV)) and low-dose dexamethasone (LoDEX) in lenalidomide-refractory and proteasome inhibitor-exposed relapsed or relapsed and refractory multiple
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3583d0256a39426910cc173ed97604d6
https://pubmed.ncbi.nlm.nih.gov/28642620
https://pubmed.ncbi.nlm.nih.gov/28642620
We respond to calls to incorporate the broader institutional context in which partner selection decisions occur into the study of partner selection. We examine the neglected question concerning how varying institutional distance between potential par
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______645::1d0a2cd187fe50e38bd2fbf9aad9dabe
http://wps-feb.ugent.be/Papers/wp_12_796.pdf
http://wps-feb.ugent.be/Papers/wp_12_796.pdf
Autor:
Steven S. Yang, Yun Ju Kim, C. Sung, L. Law, D. S. Siegel, Sanjaya K. Satapathy, B. DeVito, A. Volfson, Barak Friedman
Publikováno v:
Endoscopy. 43
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bea270c19d2e41cb7c509361e55430b2
https://pubmed.ncbi.nlm.nih.gov/22020707
https://pubmed.ncbi.nlm.nih.gov/22020707
Autor:
D S Siegel, P Richardson, M Dimopoulos, P Moreau, C Mitsiades, D Weber, J Houp, C Gause, S Vuocolo, J Eid, T Graef, K C Anderson
Publikováno v:
Blood Cancer Journal. 4:e202-e202
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4bbe6f440b3289e0624600ce984e25e9
https://doi.org/10.1038/bcj.2014.23
https://doi.org/10.1038/bcj.2014.23
Publikováno v:
Blood. 93(9)
The molecular mechanisms by which multiple myeloma (MM) cells evade glucocorticoid-induced apoptosis have not been delineated. Using a human IgAkappa MM cell line (ARP-1), we found that dexamethasone (Dex)-induced apoptosis is associated with decreas
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::d357b08281f36853ea949aae83a14444
https://pubmed.ncbi.nlm.nih.gov/10216101
https://pubmed.ncbi.nlm.nih.gov/10216101
Autor:
D S, Siegel, K R, Desikan, J, Mehta, S, Singhal, A, Fassas, N, Munshi, E, Anaissie, S, Naucke, D, Ayers, D, Spoon, D, Vesole, G, Tricot, B, Barlogie
Publikováno v:
Blood. 93(1)
Multiple myeloma (MM) typically afflicts elderly patients with a median age of 65 years. However, while recently shown to provide superior outcome to standard treatment, high-dose therapy (HDT) has usually been limited to patients up to 65 years. Amo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::77bd6a4d6023cbfc0602fa79adc2feef
https://pubmed.ncbi.nlm.nih.gov/9864145
https://pubmed.ncbi.nlm.nih.gov/9864145
Autor:
R. Feinman, Richard A. Rifkind, Joseph Michaeli, Andrew D. Zelenetz, D. S. Siegel, T. Teitz, Victoria M. Richon, Paul A. Marks, Xiuguo Zhang
Multiple myeloma (MM) is a B cell malignancy characterized by the expansion of monoclonal Ig-secreting plasma cells with low proliferative activity. It is postulated that inhibition of physiologic cell death is an underlying factor in the pathophysio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7c6bcbef32e4d922ae12a080be42a9a0
https://europepmc.org/articles/PMC18160/
https://europepmc.org/articles/PMC18160/
Publikováno v:
Current topics in microbiology and immunology. 224
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::da6053edcfa1ac4dfdcaa33683663cd6
https://pubmed.ncbi.nlm.nih.gov/9308249
https://pubmed.ncbi.nlm.nih.gov/9308249
Publikováno v:
A Multidisciplinary Approach to Myelin Diseases ISBN: 9781475703566
Globoid cell leukodystrophy (GLD, Krabbe disease) is a rare genetic disorder caused by a catalyc deficiency of galactosylceramide (EC 3.2.1.46) (Suzuki and Suzuki, 1970). One of the unusual features of the disease is the absence of abnormal accumulat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::adf4b5f1f92d6de73e40c057f5f50434
https://doi.org/10.1007/978-1-4757-0354-2_23
https://doi.org/10.1007/978-1-4757-0354-2_23